# MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa

> **NCT02933281** · PHASE1,PHASE2 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 144 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** MTBVAC
- **BIOLOGICAL:** BCG

## Key facts

- **NCT ID:** NCT02933281
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-14
- **Primary completion:** 2021-09-05
- **Final completion:** 2021-09-05
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2023-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933281, "MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02933281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*